Trending...
- Leeds Billboard Campaign Drives 188% Traffic Uplift as AI Enquiries Rise 266% for Loud! OOH
- Brother Marcus Unlocks the Vault
- AI, Drones, Defense & Explosive Growth: Why ZenaTech Is Emerging as One of the Most Compelling Technology Growth Stories (N A S D A Q: ZENA)
CHADDS FORD, Pa., Sept. 20, 2023 ~ ClariMed, Inc., a MedTech services partner that prioritizes usability as the core of their integrated, human-centric approach to medical product development, has announced the appointment of Dr. Sandrine Parkins as Head of Operations for Harvey Medical, a ClariMed company.
Dr. Parkins brings over 25 years of experience in technical consultancy and a passion for developing high-performing, engaged, and autonomous teams to her new role. Prior to joining Harvey Medical, she served in progressively responsible roles for Team Consulting for over fifteen years.
Kelley Kendle, CEO of ClariMed expressed her enthusiasm about the appointment saying "We are thrilled to have Sandrine join us to continue our commitment to operational excellence within ClariMed. She adds to the professionalism of our team, and her years of leadership within a consultancy are just what we need to continue to build our foundation for growth."
More on The PennZone
Louisa Harvey, Principal of Harvey Medical added "Sandrine will be instrumental not only in refining and maintaining Harvey Medical operations but also in harnessing and integrating the combined strengths of the entire ClariMed organization. We truly are 'stronger together' when we can attract such great talent to our team."
In her new role at Harvey Medical, Dr. Parkins will spearhead operations focusing on project planning and delivery, resourcing, and talent management while ensuring a robust infrastructure for business processes and systems that will bolster Harvey Medical's performance and ClariMed's broader growth and efficiency.
Dr. Parkins expressed her delight at joining such a young and dynamic team saying "I see the immense potential of the ClariMed companies and look forward to ensuring that our systems and infrastructure effectively deliver our collective value to our clients."
Dr. Parkins will be based out of the Harvey Medical Cambridge office.
Dr. Parkins brings over 25 years of experience in technical consultancy and a passion for developing high-performing, engaged, and autonomous teams to her new role. Prior to joining Harvey Medical, she served in progressively responsible roles for Team Consulting for over fifteen years.
Kelley Kendle, CEO of ClariMed expressed her enthusiasm about the appointment saying "We are thrilled to have Sandrine join us to continue our commitment to operational excellence within ClariMed. She adds to the professionalism of our team, and her years of leadership within a consultancy are just what we need to continue to build our foundation for growth."
More on The PennZone
- From DJ Booths to Disney: Orlando Author Ryan Tiffin Launches "Chasing Magic"
- Nola Blue Records Announces New Album from Sherman Holmes
- FDA Food Recall Notices After Outbreak Linked to 98 Hospitalizations: Practical Tips for Safer Grocery Shopping
- The 'Tax Squeeze': Betsson's Record Quarter Previews the Economics of Finland's 2027 Casino Market
- Colonial Nissan Helps Multiple Generations of the Community Find Their Next Vehicle
Louisa Harvey, Principal of Harvey Medical added "Sandrine will be instrumental not only in refining and maintaining Harvey Medical operations but also in harnessing and integrating the combined strengths of the entire ClariMed organization. We truly are 'stronger together' when we can attract such great talent to our team."
In her new role at Harvey Medical, Dr. Parkins will spearhead operations focusing on project planning and delivery, resourcing, and talent management while ensuring a robust infrastructure for business processes and systems that will bolster Harvey Medical's performance and ClariMed's broader growth and efficiency.
Dr. Parkins expressed her delight at joining such a young and dynamic team saying "I see the immense potential of the ClariMed companies and look forward to ensuring that our systems and infrastructure effectively deliver our collective value to our clients."
Dr. Parkins will be based out of the Harvey Medical Cambridge office.
0 Comments
Latest on The PennZone
- BTAQ Unveils Easier Photo Upload Capabilities
- K2 Integrity Names Michael Kallabat Global Head of Investigations and Disputes
- WebDrafter Highlights How AI Search Is Reshaping Online Visibility
- Socialhose Eyes Southeast Asia and Rejects the Copy-Paste Expansion Playbook
- $40 Billion Global Market Value by 2030 Projected in Unmanned Aerial Vehicle or Other Drone Technology Sector, Growing at 9.2% Compound Annual Growth
- A.M. Logging Returns to Ag Progress Days for Eighth Year
- $620 Million in Recent Government Contract Awards with More Than $1.2 Billion in Annualized Revenue: Circle8 Group (N A S D A Q: CIRC)
- Lewis County Hydrogen Alliance Launches Phase 1 Work to Turn Forest Residuals into Fuel-Grade Hydrogen and Dispatchable Clean Power
- Next Gen Fibre Selects netElastic vBNG and CGNAT to Fuel Rapid Nationwide Expansion and Eliminate Network Bottlenecks
- Boston Industrial Solutions, Inc. Introduces SAP-G70 Primer for bonding silicone to silicone and other materials
- 'Reflections: Enlightening Insights Into the Divine Mystery' — The Latest Book by Philosopher Steven Colborne
- Scott G. Hoy of Hoy Law Earns 11th Consecutive Super Lawyers Selection
- Brother Marcus Unlocks the Vault
- L2 Aviation Selected for U.S. Air Force KC-46 CASPER Multiple Award Contract
- Leeds Billboard Campaign Drives 188% Traffic Uplift as AI Enquiries Rise 266% for Loud! OOH
- Sister Files Lawsuit Against Georgia Funeral Home for Alleged Mishandling of Brother's Remains
- KeysCaribbean Resorts Offer Savings On Summer Vacations Now Through Aug. 31
- Crossroads4Hope Announces The Lipschutz Women's Fund
- AI, Drones, Defense & Explosive Growth: Why ZenaTech Is Emerging as One of the Most Compelling Technology Growth Stories (N A S D A Q: ZENA)
- 91 Per Cent of Enterprises Will Increase AI Spending. Most Can't See the Cost — or the Risk!